Gujarat Themis Biosyn Limited (NSE:GUJTHEM)
India · Delayed Price · Currency is INR 364.55
+0.60 (0.16%)
Jul 21, 2026, 3:29 PM IST
Gujarat Themis Biosyn Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 39.71 billion as of July 21, 2026. Its market cap has decreased by -0.63% in one year.
Market Cap
39.71B
Enterprise Value
41.26B
Revenue
1.66B
Ranking
n/a
PE Ratio
85.06
Stock Price
364.55
ChartMarket Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 39.71B, an increase of 114,000.69%. That is a compound annual growth rate of 33.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 39.57B | -17.92% |
| Dec 31, 2025 | 48.21B | 44.85% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 76.33B |
| Aarti Pharmalabs | 64.18B |
| Innova Captab | 55.09B |
| Orchid Pharma | 52.82B |
| RPG Life Sciences | 47.30B |
| Solara Active Pharma Sciences | 27.50B |
| Indoco Remedies | 22.84B |
| Beta Drugs | 22.50B |